Uni-Bio Science Announces 2022 Annual Results，Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships
2023-03-28
View details
From February 23, Uni-Bio Science Group's 2023 Annual Strategy Conference was held in Beijing, attended by the Chairman, CEO, heads and colleagues of the BU.
2023-03-13
View details
From February 15 to 17, Uni-Bio Science Group's 2023 Annual Marketing Conference was held in Xiamen, attended by the Chairman and CEO of Uni-Bio and all front-line marketing backbones from all units across the country. Embarking on a new journey, many new
2023-03-01
View details
[HONG KONG, February 16, 2023] Recently, Inaugural Hong Kong Innopreneur Award Presentation Ceremony was successfully held in Hong Kong.
2023-02-17
View details
Uni-Bio Science Group Limited is pleased to announce its interim results for six months ended 30 June 2022 (the “Period”), as well as its comparative figures for six months ended 30 June 2021.
2022-08-29
View details
京公网安备 11011402013046号京ICP备17029593号-2
